NatureWise Biotech & Medicals Corp

Chart & Performance

D1W1MN

P/E

—

P/S

4.82

EPS

—

Div Yield, %

1.16%

Shrs. gr., 5y

-0.22%

Rev. gr., 5y

-10.45%

Revenues

177m

-21.20%

Net income

-118m

CFO

-113m

L+3,928.66%

Dividend

Aug 27, 20240.2 TWD/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Profile

NatureWise Biotech & Medicals Corporation is a Taiwanese entity primarily engaged in the creation of pharmaceutical solutions. Its product lineup features LipoCol Forte, a capsule designed to address elevated cholesterol and triglyceride levels; PPL Taiwan green propolis; and NBM-BMX, an oral softgel formulation specifically developed for oncology treatment. The company was established in 2000 and maintains its headquarters in Taipei, Taiwan.

URL

https://www.naturewise.com.tw/

IPO date

Dec 25, 2007

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title TWD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title TWD in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT